bosutinib
Bogus Isomer Vendors Identified
Sabrina Richards | May 25, 2012
Pharma company publishes a list of 17 companies known to have sold the incorrect isomer of the kinase inhibitor bosutinib.
Mismarketed Chemical Causes Concern
Sabrina Richards | May 13, 2012
An incorrect isomer of the kinase inhibitor bosutinib is circulating in the biomedical research community, potentially throwing doubt on study results.